BARK (BARK) 10-Q 10 Aug 21 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Jun. 30, 2021	Aug. 06, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-39691
Entity Registrant Name	THE ORIGINAL BARK COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-4109918
Entity Address, Address Line One	212 Canal Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10013
City Area Code	855
Local Phone Number	501-2275
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		168,315,015
Entity Central Index Key	0001819574
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--03-31
Amendment Flag	false
Common Stock, par value $0.0001
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	BARK
Security Exchange Name	NYSE
Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Document Information [Line Items]
Title of 12(b) Security	Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	BARK WS
Security Exchange Name	NYSE
Former Address
Document Information [Line Items]
Entity Address, Address Line One	221 Canal Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10013

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 321,000	$ 38,278
Accounts receivable—net	8,127	8,927
Prepaid expenses and other current assets	5,359	7,409
Inventory	102,305	77,454
Total current assets	436,791	132,068
PROPERTY AND EQUIPMENT—NET	18,999	13,465
INTANGIBLE ASSETS—NET	2,445	2,070
OTHER NONCURRENT ASSETS	4,421	3,260
TOTAL ASSETS	462,656	150,863
CURRENT LIABILITIES:
Accounts payable	33,194	50,501
Accrued and other current liabilities	77,560	44,605
Deferred revenue	30,654	27,177
Total current liabilities	141,408	122,283
LONG-TERM DEBT	71,583	115,729
OTHER LONG-TERM LIABILITIES	7,818	11,834
Total liabilities	220,809	249,846
COMMITMENTS AND CONTINGENCIES
REDEEMABLE CONVERTIBLE PREFERRED STOCK:
Redeemable convertible preferred stock	0	59,987
STOCKHOLDERS’ DEFICIT:
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 166,704,484 shares issued and outstanding as of June 30, 2021 and 17,000,000 shares authorized; 5,498,588 shares issued and outstanding as of March 31, 2021.	1	0
Treasury stock, at cost	0	(4,764)
Additional paid-in capital	446,602	25,748
Accumulated deficit	(204,756)	(179,954)
Total stockholders’ equity (deficit)	241,847	(158,970)
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT	462,656	150,863
Convertible Redeemable Preferred Stock
REDEEMABLE CONVERTIBLE PREFERRED STOCK:
Redeemable convertible preferred stock	$ 0	$ 59,987

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Statement of Financial Position [Abstract]
Convertible preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Convertible preferred stock, liquidation preference	$ 0	$ 62,800
Convertible preferred stock, shares authorized (in shares)	0	8,010,560
Convertible preferred stock, shares issued (in shares)	0	7,752,515
Convertible preferred stock, shares outstanding (in shares)	0	7,752,515
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	17,000,000
Common stock, shares issued (in shares)	166,704,484	5,498,588
Common stock, shares outstanding (in shares)	166,704,484	5,498,588

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
REVENUE	$ 117,606,000	$ 74,808,000
COST OF REVENUE	47,815,000	27,888,000
Gross profit	69,791,000	46,920,000
OPERATING EXPENSES:
General and administrative	69,471,000	32,036,000
Advertising and marketing	17,178,000	11,575,000
Total operating expenses	86,649,000	43,611,000
LOSS FROM OPERATIONS	(16,858,000)	3,309,000
INTEREST EXPENSE	(1,561,000)	(1,514,000)
OTHER INCOME—NET	(6,385,000)	221,000
NET INCOME (LOSS) BEFORE INCOME TAXES	(24,804,000)	2,016,000
PROVISION FOR INCOME TAXES	0	0
NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)	(24,804,000)	2,016,000
NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)	$ (24,804,000)	$ 2,016,000
Net income (loss) per common share attributable to common stockholders - basic (USD per share)	$ (0.23)	$ 0.08
Weighted-average common shares used to computed net income (loss) per share attributable to common stockholders - basic (in shares)	108,762,540	5,206,474
Net income (loss) per common share attributable to common stockholders - diluted (USD per share)	$ (0.23)	$ 0.05
Weighted-average common shares used to compute net income (loss) per share attributable to common stockholders - diluted (in shares)	108,762,540	9,586,378

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit
Convertible Redeemable Preferred stock, beginning balance (in shares) at Mar. 31, 2020	7,752,515
Convertible Redeemable Preferred Stock, beginning balance at Mar. 31, 2020	$ 59,987
Convertible Redeemable Preferred Stock, ending balance (in shares) at Jun. 30, 2020	7,752,515
Convertible Redeemable Preferred Stock, ending balance at Jun. 30, 2020	$ 59,987
Shares outstanding, beginning balance (in shares) at Mar. 31, 2020		5,196,711	(259,953)
Beginning balance at Mar. 31, 2020	(135,387)	$ 0	$ (4,755)	$ 17,931	$ (148,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,016				2,016
Issuance for stock options exercised (in shares)		31,363
Issuance for stock options exercised	222			222
Stock-based compensation	388			388
Shares outstanding, ending balance (in shares) at Jun. 30, 2020		5,228,074	(259,953)
Ending balance at Jun. 30, 2020	$ (132,761)	$ 0	$ (4,755)	18,541	(146,547)
Convertible Redeemable Preferred stock, beginning balance (in shares) at Mar. 31, 2021	7,752,515
Convertible Redeemable Preferred Stock, beginning balance at Mar. 31, 2021	$ 59,987
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of Preferred Shares (in shares)	(7,752,515)
Conversion of Preferred Shares	$ (59,987)
Convertible Redeemable Preferred Stock, ending balance (in shares) at Jun. 30, 2021	0
Convertible Redeemable Preferred Stock, ending balance at Jun. 30, 2021	$ 0
Shares outstanding, beginning balance (in shares) at Mar. 31, 2021		5,498,588	(259,953)
Beginning balance at Mar. 31, 2021	(158,970)	$ 0	$ (4,764)	25,748	(179,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(24,804)				(24,804)
Issuance for stock options exercised (in shares)		424,384
Issuance for stock options exercised	197			197
Issuance for warrants exercised (in shares)		231,153
Issuance for warrants exercised	104			104
Cumulative translation adjustment	2				2
Stock-based compensation	3,098			3,098
Conversion of Preferred Shares (in shares)		7,752,515
Conversion of Preferred Shares	59,987			59,987
Conversion of Convertible Notes (in shares)		1,135,713
Conversion of Convertible Notes	11,976			11,976
PIPE Issuance (in shares)		20,000,000
PIPE Issuance	200,000			200,000
Net equity infusion from the Merger (in shares)		131,662,131	(259,953)
Net equity infusion from the Merger	150,257	$ 1	$ 4,764	145,492
Shares outstanding, ending balance (in shares) at Jun. 30, 2021		166,704,484	0
Ending balance at Jun. 30, 2021	$ 241,847	$ 1	$ 0	$ 446,602	$ (204,756)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (24,804)	$ 2,016
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation & amortization	844	509
Amortization of deferred financing fees and debt discount	346	345
Bad debt expense	0	107
Stock-based compensation expense	3,098	388
Loss on extinguishment of debt	2,598	0
Change in fair value of warrant liabilities and derivatives	3,899	34
Change in fair value of warrant liabilities and derivatives
Accounts receivable	818	(244)
Inventory	(24,851)	(6,690)
Prepaid expenses and other current assets	(1,329)	(424)
Other assets	(337)	0
Accounts payable and accrued expenses	(13,683)	(3,418)
Deferred revenue	3,478	4,807
Other liabilities	(11,948)	4,044
Net cash provided by (used in) operating activities	(61,871)	1,474
CASH FLOWS FROM INVESTING ACTIVITIES:
Capitalized expenditures	(8,305)	(210)
Net cash used in investing activities	(8,305)	(210)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Payments of finance fees	(494)	(42)
Payments of transaction costs	(24,667)	0
Payment of deferred underwriting fees	(8,902)	0
Payment of capital lease obligations	(150)	0
Proceeds from equity infusion from the Merger, net of redemptions	227,092	0
Proceeds from PIPE issuance	200,000	0
Proceeds from the exercise of stock options	197	222
Proceeds from the exercise of warrants	104	0
Proceeds from convertible notes	0	1,000
Proceeds from debt	0	5,157
Payments of long-term debt	(39,457)	0
Net cash provided by financing activities	353,723	6,337
Effect of exchange rate changes on cash	2	0
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	283,547	7,601
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—BEGINNING OF PERIOD	39,731	9,676
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—END OF PERIOD	323,278	17,277
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
Cash and cash equivalents	321,000	17,277
Restricted cash—Prepaid expenses and other current assets	2,278	0
Total cash, cash equivalents and restricted cash	323,278	17,277
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Purchases of property and equipment included in accounts payable and accrued liabilities	1,552	49
Cash paid for interest	702	1,236
Cash paid for sales tax	12,934	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of preferred stock to common stock	59,987	0
Capital contribution related to extinguishment of debt	688	0
Non-cash deferred issuance cost	0	25
Issuance of derivatives with debt	0	1,153
2025 Convertible Notes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock related to convertible notes	12,793	0
Convertible promissory notes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock related to convertible notes	$ 0	$ 800

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	3 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	ORGANIZATION AND DESCRIPTION OF BUSINESS The Original BARK Company (the “Company”), a Delaware corporation formerly known as Northern Star Acquisition Corp. ("Northern Star") , is an omnichannel brand serving dogs across the four key categories of Play, Food, Health and Home. The Company is located and headquartered in New York, New York. On June 1, 2021 (the “Closing Date”), Northern Star completed the acquisition of Barkbox, Inc. (“Legacy BARK”), a Delaware corporation, pursuant to that certain Agreement and Plan of Reorganization (the “Merger Agreement”), dated December 16, 2020, by and among Northern Star, NSAC Merger Sub Corp., a Delaware corporation and wholly-owned subsidiary of Northern Star (“Merger Sub”), and Legacy Bark. At the Closing, Merger Sub merged with and into Legacy BARK, with Legacy BARK surviving the merger as a wholly owned subsidiary of Northern Star (the “Merger” and, collectively with the other transactions described in the Merger Agreement, the “Business Combination”). Also at the Closing, Northern Star changed its name to “The Original BARK Company.” The Merger was accounted for as a reverse recapitalization with Legacy BARK as the accounting acquirer and Northern Star as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy BARK and its wholly owned subsidiaries as if Legacy BARK is the predecessor to the Company. Prior to the Merger, Northern Star ordinary shares and warrants were traded on the New York Stock Exchange (“NYSE”) under the ticker symbols “STIC” and “STIC WS,” respectively. On the Closing Date, the Company's common stock and warrants began trading on the NYSE under the ticker symbols “BARK” and “BARK WS,” respectively. See Note 3, “Merger,” for additional details.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation —The accompanying condensed consolidated financial statements include the accounts of The Original BARK Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s audited consolidated financial statements as of and for the years ended March 31, 2021 and 2020. The consolidated balance sheet as of March 31, 2021, included herein, was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by U.S. GAAP, required on an annual reporting basis. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods. The results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, the year ending March 31, 2022, or any other period. Except as described elsewhere in this Note 2 and in Note 3, “Merger”, there have been no material changes to the Company’s significant accounting policies as described in the audited consolidated financial statements as of March 31, 2021 and 2020. Although the Company has incurred recurring losses in each year since inception, the Company expects its cash and cash equivalents will be sufficient to fund operations for at least the next twelve months. Use of Estimates— The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions. The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. Except with respect to estimates related to the warrant liabilities, there have been no material changes to the Company’s use of estimates as described in the audited consolidated financial statements as of March 31, 2021. Impact of the COVID-19 Pandemic —The Company is closely monitoring the impact of the COVID-19 pandemic, including the emergence and spread of variants of COVID-19, on the U.S. and global economies and on the Company’s operating results, financial condition and cash flows. The estimates of the impact COVID-19 may have on the Company’s business may change based on new information that may emerge concerning COVID-19, the actions to contain it or treat its impact and the economic impact on local, regional, national and international markets. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise the estimates reflected in its condensed consolidated financial statements. Fair Value of Financial Instruments —The Company’s financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses, are carried at historical cost. At June 30, 2021 and March 31, 2021, the carrying amounts of these instruments approximated their fair values because of their short-term nature. The carrying amounts of the Company’s long-term debt approximate the fair value based on consideration of current borrowing rates available to the Company. Assets and liabilities recorded at fair value on a recurring basis in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: Level 1 —Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2 —Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and Level 3 —Unobservable inputs that are supported by little or no market data for the related assets or liabilities. The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following summarizes assets and liabilities that are measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands): As of June 30, 2021 Level 1 Level 2 Level 3 Total Liabilities Public warrant liability (1) $ 29,505 $ — $ — $ 29,505 Private warrant liability (1) $ — $ 15,862 $ — $ 15,862 Common stock warrant liability (1) $ — $ — $ 797 $ 797 $ 29,505 $ 15,862 $ 797 $ 46,164 As of March 31, 2021 Level 1 Level 2 Level 3 Total Liabilities Preferred stock warrant liabilities (1) $ — $ — $ 133 $ 133 Derivative liabilities (2) — — $ 4,883 $ 4,883 $ — $ — $ 5,016 $ 5,016 ______________ (1) Included in accrued and other current liabilities. (2) Included in other long-term liabilities. The Company’s outstanding warrants include publicly-traded warrants (the “Public Warrants”) which were issued as one-third of a warrant per unit issued during the Company’s initial public offering on November 10, 2020 (the “IPO”), warrants sold in a private placement to Northern Star’s sponsor (the “Private Warrants”), and preferred share warrants issued by Legacy BARK which were assumed by the Company in connection with the Merger and exchanged into warrants for BARK common stock (the “Common Stock Warrants”). The Company evaluated its warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and concluded that they do not meet the criteria to be classified in stockholders’ equity. Since the Public Warrants and Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as current liabilities on the balance sheet at fair value upon the Closing of the Merger, with subsequent changes in their respective fair values recognized in other income, net on the condensed consolidated statements of operations and comprehensive loss at each reporting date. Restricted Cash —The Company has restricted cash with its primary banks related to customs bonds required for the importing of goods. As of June 30, 2021 and March 31, 2021, the Company has classified $2.3 million and $1.5 million within prepaid expenses and other current assets, as restricted cash. Concentration of Credit Risk and Major Customers and Suppliers —Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with various domestic financial institutions of high credit quality. The Company’s accounts receivable are derived from sales contracts with large retail customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary. Significant customers are those that represent more than 10% of the Company’s total revenues or gross accounts receivable balance at each balance sheet date. For the three months ended June 30, 2021 and 2020, the Company did not have any customers that accounted for 10% or more of total revenues. The Company had three customers that accounted for 75% and three customers that accounted for 84% of gross accounts receivable as of June 30, 2021 and March 31, 2021, respectively. Significant suppliers are those that represent more than 10% of the Company’s total finished goods purchased or accounts payable at each balance sheet date. During the three months ended June 30, 2021 and 2020, the Company had two suppliers that accounted for 35% and two suppliers that accounted for 40% of total finished goods purchased, respectively. The Company had two suppliers that accounted for 30% and and two suppliers that accounted for 44% of the accounts payable balance as of June 30, 2021 and March 31, 2021, respectively. Recent Accounting Pronouncements Issued but Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the consolidated financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The standard is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company plans to adopt this standard on April 1, 2022 and is continuing to evaluate the expected impact that the standard will have on its consolidated financial statements and related disclosures In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments , which requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. This guidance in the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the impact that the adoption will have on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which is intended to simplify the accounting for income taxes. This updated removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The new standard will be effective beginning April 1, 2022. The Company does not expect the adoption of ASU 2019-12 to have a material impact on the Company’s consolidated financial statements.

MERGER

MERGER	3 Months Ended
	Jun. 30, 2021
Reverse Recapitalization [Abstract]
MERGER	MERGER On June 1, 2021, the Company consummated the Merger pursuant to the terms of the Merger Agreement, by and among the Company, NSAC Merger Sub, and Legacy BARK. Immediately upon the consummation of the Merger and the other transactions contemplated by the Merger Agreement (collectively, the “Transactions”, and such completion, the “Closing”), Merger Sub merged with and into Legacy BARK, with Legacy BARK surviving the Business Combination as a wholly-owned subsidiary of the Company. In connection with the Transactions, the Company changed its name to “The Original BARK Company”. The Merger is accounted for as a reverse recapitalization in accordance with U.S. GAAP primarily due to the fact that Legacy BARK stockholders continue to control the Company post the closing of the Merger. Under this method of accounting, Northern Star is treated as the “acquired” company for accounting purposes and the Merger is treated as the equivalent of Legacy BARK issuing stock for the net assets of Northern Star, accompanied by a recapitalization. The net assets of Northern Star will be stated at historical cost, with no goodwill or other intangible assets recorded. Pursuant to the Merger, at the Effective Time of the Merger (the “Effective Time”), each stockholder of Legacy BARK’s common and preferred stock, (including stockholders issued common stock as a result of the conversion of BARK’s outstanding convertible promissory notes issued in 2019 and 2020 (other than the 2025 Convertible Notes - see Note 5, “Debt”)) received 8.7425 shares of the Company’s common stock, par value $0.0001 per share, per share of Legacy BARK’s common stock and preferred stock, respectively, owned by such Legacy BARK stockholder that was outstanding immediately prior to the Closing. In addition, pursuant to the terms of the Merger Agreement, at the effective time of the Merger, (1) options to purchase shares of BARK’s common stock were converted into options to purchase an aggregate of 29,257,576 shares of the Company's common stock and (2) warrants to purchase shares of Legacy BARK’s common and redeemable convertible preferred stock were converted into warrants to purchase an aggregate of 1,897,212 shares of the Company's common stock. Additionally, at the Closing: • The conversion obligations with respect to Legacy BARK’s 5.50% convertible senior secured notes due 2025 (the “2025 Convertible Notes”) were assumed by the Company and the 2025 Convertible Notes became convertible at the election of the holders into shares of the Company's common stock. As of the Closing, the 2025 Convertible Notes were convertible at the election of the holder into an aggregate of 7,713,121 shares of the Company's common stock based on the then outstanding principal and accrued interest. The 2025 Convertible Notes are still outstanding as of June 30, 2021; • certain investors (the “PIPE Investors”) purchased an aggregate of 20,000,000 shares of the Company's common stock in a private placement at a price of $10.00 per share for an aggregate purchase price of $200,000,000 (the “PIPE” issuance); • each of the 6,358,750 outstanding shares of Northern Star’s Class B common stock were converted into a share of the Company's common stock on a one-for-one basis. Each outstanding warrant of Northern Star entitles the holder to purchase shares of the Company's common stock at a price of $11.50 per share beginning on November 13, 2021. • the Company amended and restated its amended and restated certificate of incorporation, increasing the number of shares of common stock authorized to issue to 500,000,000 shares.

REVENUE FROM CONTRACTS WITH CUS

REVENUE FROM CONTRACTS WITH CUSTOMERS	3 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	REVENUE FROM CONTRACTS WITH CUSTOMERSThe Company’s standard payment terms vary but do not result in a significant delay between the timing of invoice and payment. The Company occasionally negotiates other payment terms during the contracting process for its retail business. The Company has elected the practical expedient to not adjust the total consideration within a contract to reflect a financing component when the duration of the financing is one year or less. Disaggregated Revenue Revenue disaggregated by significant revenue stream for the three-months ended June 30, 2021 and 2020 were as follows (in thousands): Three Months Ended June 30, 2021 2020 Revenue Direct to Consumer: Toys and treats subscription $ 103,089 $ 65,608 Other $ 2,287 $ 1,491 Total Direct to Consumer $ 105,376 $ 67,099 Commerce $ 12,230 $ 7,709 Revenue $ 117,606 $ 74,808 Contract Liability The Company’s contract liability represents cash collections from its customers prior to delivery of subscription products, which is recorded as deferred revenue on the condensed consolidated balance sheets. Deferred revenue is recognized as revenue upon the delivery of the box or product. Contractual liabilities included in deferred revenue were $30.7 million and $27.2 million as of June 30, 2021 and March 31, 2021, respectively. During the three months ended June 30, 2021, the Company recognized $4.8 million of revenue included in deferred revenue as of March 31, 2021. Performance Obligations

DEBT

DEBT	3 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
DEBT	DEBT As of June 30, 2021 and March 31, 2021, long-term debt consisted of the following (in thousands): As of June 30, As of March 31, 2021 2021 2025 Convertible Notes $ 75,000 $ 75,000 Western Alliance revolving line of credit & term loan $ — $ 34,300 Convertible promissory notes $ — $ 7,167 PPP loan $ — $ 5,157 $ 75,000 $ 121,624 Less: deferred financing fees and debt discount $ (3,417) $ (5,895) Total long-term debt $ 71,583 $ 115,729 Western Alliance Bank—Line of Credit and Term Loan In October 2017, the Company entered into a new loan and security agreement (the “Western Alliance Agreement”) and issued a warrant to purchase preferred stock (“Initial Western Alliance Warrant”) to Western Alliance Bank (“Western Alliance”), which provided for a secured revolving line of credit (the “Credit Facility”) in an aggregate principal amount of up to $35.0 million with a maturity date of October 12, 2020. On December 7, 2018, the Company amended the Western Alliance Agreement, which included the issuance of a warrant to purchase common stock (“Subsequent Western Alliance Warrant”) to Western Alliance. The modification to the Western Alliance Agreement provided for an additional term loan of $10.0 million at issuance and an incremental seasonal loan of $5.0 million. The seasonal loan matured and was repaid on March 31, 2020. The term loan matures December 31, 2021. On July 31, 2020, the Company amended the Western Alliance Agreement and extended the expiration of the warrants to July 31, 2030. The modification to the Western Alliance Agreement amended the maturity date of the Credit Facility to August 12, 2021. On November 27, 2020, the Company repaid the outstanding $10.0 million principal of the term loan with Western Alliance Bank, as well as $0.2 million of early repayment fees, using proceeds from the issuance of the 2025 Convertible Notes (the “2025 Convertible Notes”). See further discussion of the 2025 Convertible Notes issuance below. In conjunction with the 2025 Convertible Notes issuance, the Company amended the Western Alliance Agreement to extend the Credit Facility repayment date from August 12, 2021 to December 31, 2021. On January 22, 2021, the Company amended the Western Alliance Agreement to extend the Credit Facility maturity date to May 31, 2022. The interest rate for borrowings under the Credit Facility, as amended, is equal to (i) the greater of the prime rate that is published in the Money Rates section of The Wall Street Journal from time to time (the “Prime Rate”) and 5.25%, plus (ii) half of one percent (0.50%), per annum. The Credit Facility has a borrowing base subject to an amount equal to eighty percent (80.00%) of the Company’s trailing three months of subscription revenue. Western Alliance has first perfected security in substantially all of the Company’s assets, including its rights to its intellectual property. As of March 31, 2021, the Company had $34.3 million of outstanding borrowings under the Credit Facility, recorded as debt on the accompanying consolidated balance sheets. On June 15, 2021, in connection with the Merger, the Company repaid the outstanding balance on the Credit Facility, and as of June 30, 2021 there are no outstanding borrowings under the Credit Facility. The full amount of the Credit Facility of $35.0 million remains available to be borrowed by the Company if or when needed through the termination date of the agreement of May 31, 2022. Under the terms of this Credit Facility, the Company is required to comply with certain financial and nonfinancial covenants, including covenants to maintain certain liquidity amounts, as defined in the amended Western Alliance Agreement. As of June 30, 2021 and March 31, 2021, the Company was compliant with its financial covenants. Convertible Promissory Notes On December 19, 2019, the Company entered into a note purchase agreement and issued individual convertible promissory notes thereunder (the “2019 Notes”), with an option for subsequent closings through May 1, 2020 for up to $10.0 million in aggregate principal. The Company received gross proceeds of $3.9 million in two December 2019 closings. The 2019 Notes bore interest at a rate of 7% per year, capitalized quarterly, and payable in kind (“PIK Interest”). The 2019 Notes had a maturity date of December 19, 2024, unless previously converted into equity securities pursuant to the terms of the note purchase agreement. On March 31, 2020, the Company entered into a note purchase agreement and issued individual convertible promissory notes thereunder (the “2020 Notes”), with an option for subsequent closings through May 1, 2020 for up to $10.0 million in aggregate principal. The Company received gross proceeds of $1.5 million from the initial closing of the note purchase agreement on March 31, 2020 with employees, founders, and existing investors, representing a related party transaction. The agreement consisted of both Pro Rata Notes and a Super Pro Rata Note. Pro-Rata Notes are defined as one or more promissory notes issued to each lender with respect to the amount of the lender’s consideration, up to the lender’s pro rata amount as set forth in the note purchase agreement. Super Pro-Rata Notes are defined as one or more promissory notes issued to each lender with respect to the lender’s amount of consideration paid in excess of their pro rata amount. The Super Pro Rata Notes bore interest at a rate of 10% per year, capitalized quarterly, and payable in kind (“PIK Interest”), while the Pro Rata Notes bore interest at a rate of 8% per year, capitalized quarterly, and PIK Interest. The 2020 Notes had a maturity date of March 30, 2023, unless previously converted into equity securities pursuant to the terms of the note purchase agreement. On May 1, 2020, the Company received gross proceeds of $1.0 million from the second closing of the March 31, 2020 note purchase agreement with existing investors, representing a related party transaction. On June 18, 2020, the Company amended the term loan with Pinnacle Ventures, LLC (“Pinnacle”), which extended the initial principal repayment period. In consideration of the modification, the Company issued to Pinnacle convertible promissory notes under the March 31, 2020 note purchase agreement of $0.8 million from the third closing of the March 31, 2020 note purchase agreement. On November 27, 2020, in connection with the 2025 Convertible Notes issuance, the Company entered into subordination agreements with the holders of the 2019 Notes and 2020 Notes and extended the maturity of the notes to May 30, 2026. On December 16, 2020, in connection with the execution of the Merger Agreement, the Company amended the note purchase agreements associated with the 2019 Notes and 2020 Notes to amend the conversion terms of the notes. The 2019 Notes and 2020 Notes included the following features that were assessed and determined to meet all of the criteria required to be separated as an embedded derivative from its host: • In-substance put options upon Qualified or Non-Qualified Equity Financing • Redemption (put option) upon deemed liquidation event As of March 31, 2021, the Company had $7.2 million of outstanding borrowings under the 2019 Notes and 2020 Notes. On June 1, 2021, in connection with the closing of the Merger, the outstanding principal and interest of the 2019 Notes and 2020 Notes were converted to 1,135,713 common shares of The Original Bark Company, with a fair value of $12.7 million. The conversion of the notes resulted in a loss on extinguishment of $2.6 million recorded to other expense included in other income, net on the condensed consolidated statement of operations and comprehensive loss, as well as a capital contribution of $0.7 million recorded to additional paid-in-capital on the condensed consolidated balance sheet for the portion of the loss associated with the 2020 Notes which were with related parties. Paycheck Protection Program On April 24, 2020, the Company received funds of $5.2 million under the Paycheck Protection Program (“PPP”), a part of the CARES Act. The loan was serviced by Western Alliance Bank, and the application for these funds required the Company to, in good faith, certify that the current economic uncertainty made the loan necessary to support ongoing operations. On June 11, 2021, the Company voluntarily repaid in full the outstanding principal and interest amounts of the PPP loan. 2025 Convertible Notes On November 27, 2020, the Company issued $75 million aggregate principal amount of 2025 Convertible Notes to Cede & Co. under an indenture, dated as of November 27, 2020, between Legacy BARK and U.S. Bank National Association, as trustee and collateral agent (the “Indenture”). The Company received net proceeds of approximately $74.7 million from the sale of the 2025 Convertible Notes, after deducting fees and expenses of approximately $0.3 million. The Company recorded the expenses as a discount to the note and will amortize over the term of the note. The 2025 Convertible Notes will mature on December 1, 2025, unless earlier converted, redeemed or repurchased. For a period of one year from the issuance date of the 2025 Convertible Notes, certain funds affiliated with Magnetar Financial LLC (collectively, “Magnetar”) may request the Company issue additional notes up to $25.0 million aggregate principal amount. The Company used approximately $27.6 million of the net proceeds from the sale of the 2025 Convertible Notes to repay the outstanding term loans with Western Alliance Bank and Pinnacle. The 2025 Convertible Notes are governed by the Indenture. The 2025 Convertible Notes bear interest at the annual rate of 5.50%, payable entirely in payment-in-kind annually on December 1 st of each year commencing December 1, 2021, compounded annually. If the 2025 Convertible Notes are not converted into common stock by the maturity date, the Company must repay the outstanding principal amount plus accrued interest. The 2025 Convertible Notes contain call and put options to be settled in cash contingent upon the occurrence of a change of control and a default interest rate increase of 3.0% applicable upon the occurrence of an event of default that when evaluated under the guidance of ASC 815, Derivatives and Hedging , are embedded derivatives requiring bifurcation at fair value. The fair value calculation includes Level 3 inputs including the estimated fair value of the Company’s common stock and assumptions regarding the probability that the contingent call or put will be exercised or an event of default will occur. Management determined that the probability that the contingent events will occur was near zero at inception and has remained near zero as of June 30, 2021. Therefore, the Company did not record a derivative liability related to these features at June 30, 2021. The Company will assess the probability of occurrence quarterly during the term of the 2025 Convertible Notes. As of both June 30, 2021 and March 31, 2021, the Company had $75.0 million of outstanding borrowings under the 2025 Convertible Notes agreement.

REDEEMABLE CONVERTIBLE PREFERRE

REDEEMABLE CONVERTIBLE PREFERRED STOCK	3 Months Ended
	Jun. 30, 2021
Temporary Equity [Abstract]
REDEEMABLE CONVERTIBLE PREFERRED STOCK	REDEEMABLE CONVERTIBLE PREFERRED STOCK The following table summarizes issued and outstanding redeemable convertible preferred stock of Legacy BARK as of both immediately prior to the Merger and March 31, 2021 (in thousands, except share and per share information): Redeemable Convertible Preferred Stock Shares Carrying Value Series Seed 2,057,188 $ 1,897 Series A 2,110,400 4,948 Series B 990,068 10,285 Series C 2,142,188 34,585 Series C-1 452,671 8,272 Prior to the completion of the Merger there were no significant changes to the terms of the Redeemable Convertible Preferred Stock. Upon the Closing of the Merger, the redeemable convertible preferred stock converted into common stock based on the Merger’s exchange ratio of 8.7425 of the Company’s common stock for each Legacy BARK share. The Company recorded the conversion at the carrying value of the redeemable convertible preferred stock at the time of Closing. There are no shares of redeemable convertible preferred stock authorized or outstanding as of June 30, 2021.

STOCK-BASED COMPENSTION PLANS

STOCK-BASED COMPENSTION PLANS	3 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
STOCK-BASED COMPENSTION PLANS	STOCK-BASED COMPENSATION PLANS Stock Option Plans The Barkbox, Inc. 2011 Stock Incentive Plan (as amended from time to time, the “2011 Plan”) provides for the award of stock options and other equity interests in the Company to directors, officers, employees, advisors or consultants of the Company. On June 1, 2021, in connection with the Merger, the 2021 Equity Incentive Plan (the “2021 Plan”) became effective and 16,929,505 authorized shares of common stock were reserved for issuance thereunder. In addition, pursuant to the terms of the Merger Agreement, at the effective time of the Merger, options to purchase shares of Legacy BARK’s common stock previously issued under the 2011 Plan were converted into options to purchase an aggregate of 29,390,344 shares of BARK common stock. As of June 30, 2021, 16,929,505 shares of common stock were available for the Company to grant under the 2021 Stock Plan; there were no more shares available for grant under the 2011 Plan. Beginning on April 1, 2022 and ending on (and including) March 31, 2031, the aggregate number of shares of common stock that may be issued under the 2021 Plan shall increase by a number, determined by the Company's board of directors on or before May 1st of such fiscal year, not to exceed 5% of the total number of shares of common stock issued and outstanding on the last day of the preceding fiscal year. As of the effective date of the 2021 Plan, no further stock awards have been or will be granted under the 2011 Plan. The 2011 and 2021 Plans (together, the “Plans”) are administered by the Company’s Compensation Committee of its board of directors (the “Compensation Committee”). The exercise prices, vesting and other restrictions are determined by the Board, except that the exercise price per share of a stock option may not be less than 100% of the fair value of the common share on the date of grant. Stock options awarded under the Plans typically expire 10 years after the date of the grant and generally have vesting conditions of 25% on the first anniversary of the date of grant and 75% on a monthly basis at a rate of 1/36th unless otherwise decided by the Compensation Committee. The Plans provide that the Compensation Committee shall determine the vesting conditions of awards granted under the Plans, and the Compensation Committee has from time to time approved vesting schedules for certain awards that deviate from the vesting conditions contained in the previous sentence. Stock Option Activity During the three months ended June 30, 2021 the Company granted to its employees equity awards to purchase an aggregate of 397,780 shares of common stock with a weighted average exercise price of $9.62 vesting over a four-year period. The following table summarizes the total stock-based compensation expense by function for the three months ended June 30, 2021 and 2020, which includes expense related to options, restricted stock units, and secondary sales (in thousands): Three months ended June 30, 2021 2020 General and administrative $ 3,070 $ 360 Advertising and marketing $ 28 $ 28 Total stock-based compensation expense $ 3,098 $ 388 Employee Stock Purchase Plan In June 2021, the 2021 Employee Stock Purchase Plan (the “2021 ESPP”) became effective. The 2021 ESPP authorizes the issuance of shares of common stock pursuant to purchase rights granted to employees. A total of 3,385,901 shares of common stock have been reserved for future issuance under the 2021 ESPP. On the first day of

COMMITMENT AND CONTINGENCIES

COMMITMENT AND CONTINGENCIES	3 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENT AND CONTINGENCIES	COMMITMENT AND CONTINGENCIESLitigationThe Company is party to various actions and claims arising in the normal course of business. The Company does not believe that the final outcome of these matters will have a material effect on the Company’s condensed consolidated financial position, results of operations or cash flows. However, no assurance can be given that the final outcome of such proceedings will not materially impact the Company’s condensed consolidated financial condition or results of operations.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXESThe Company did not record a federal, state, or foreign income tax provision or benefit for the three months ended June 30, 2021 due to the expected loss before income taxes to be incurred for the year ended March 31, 2022, as well as the Company’s continued maintenance of a full valuation allowance against its net deferred tax assets.

OTHER INCOME - NET

OTHER INCOME - NET	3 Months Ended
	Jun. 30, 2021
Other Income and Expenses [Abstract]
OTHER INCOME - NET	OTHER INCOME—NETOther income—net consisted of the following: Three Months Ended 2021 2020 Other income — net: Other income $ 112 $ 187 Change in fair value of warrants (3,899) — Change in fair value of derivative liability — 34 Loss on extinguishment of debt (2,598) — $ (6,385) $ 221

NET LOSS PER SHARE

NET LOSS PER SHARE	3 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NET LOSS PER SHARE Basic and diluted loss per share attributable to common stockholders were calculated as follows: Three Months Ended 2021 2020 Numerator: Net income (loss) $ (24,804) $ 2,016 Less: Earnings attributable to participating securities $ — $ (1,583) Net loss attributable to common stockholders—basic and diluted $ (24,804) $ 433 Denominator: Weighted-average number of common shares outstanding—basic and diluted 108,762,540 5,206,474 Weighted average effect of potentially dilutive securities: Effect of potentially dilutive preferred stock $ — 3,333,119 Effect of potentially dilutive stock options to purchase common stock $ — 971,920 Effect of potentially dilutive warrants to purchase common stock $ — 74,342 Effect of potentially dilutive warrants to purchase preferred stock $ — 523 Weighted average common shares outstanding—diluted 108,762,540 9,586,378 Net income (loss) per share attributable to common stockholders Net income (loss) per share attributable to common stockholders - basic $ (0.23) $ 0.08 Net income (loss) per share attributable to common stockholders - diluted $ (0.23) $ 0.05 For the three months ended June 30, 2021, the Company’s potential dilutive securities, which include stock options and warrants have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for the three months ended June 30, 2021. As the Company had net income during the three months ended June 30, 2020, the Company’s potential dilutive securities, which include preferred stock, stock options and warrants, were included in the calculation of diluted net income per share attributable to common stockholders. The Company excluded the following potential common stock, presented based on amounts outstanding at June 30, 2021 from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect. As of June 30, 2021 2020 Stock options to purchase common stock 29,225,320 — Warrants to purchase common stock 13,347,417 — 2025 convertible notes as converted to common stock 7,744,063 —

SEGMENTS

SEGMENTS	3 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
SEGMENTS	SEGMENTS The Company applies ASC 280, Segment Reporting , in determining reportable segments for its financial statement disclosure. The Company has two reportable segments: Direct to Consumer and Commerce. The Direct to Consumer segment derives revenue from the sale of BarkBox, Super Chewer, BARK Bright and BARK Eats subscriptions, as well as sales of toys and treats through the Company’s website, BarkShop. The Commerce segment derives revenue from the sale of toys, treats and BARK Home products through major retailers and online marketplaces. The Company has aggregated its product lines sold through the Company’s website into the Direct to Consumer segment. The Company has aggregated its BARK Home and Bark Retail operations into the Commerce segment. Reporting in this format provides management with the financial information necessary to evaluate the success of the segments and the overall business. There are no internal revenue transactions between the Company’s segments. The CODM reviews revenue and gross profit for both of the reportable segments. Gross profit is defined as revenue less cost of revenue incurred by the segment. The Company does not allocate assets at the reportable segment level as these are managed on an entity wide group basis and, accordingly, the Company does not report asset information by segments. Key financial performance measures of the segments including revenue, cost of revenue, and gross profit are as follows (in thousands): Three Months Ended 2021 2020 Direct to Consumer: Revenue $ 105,376 $ 67,099 Cost of revenue $ 40,819 $ 24,116 Gross profit $ 64,557 $ 42,983 Commerce: Revenue $ 12,230 $ 7,709 Cost of revenue $ 6,996 $ 3,772 Gross profit $ 5,234 $ 3,937 Consolidated: Revenue $ 117,606 $ 74,808 Cost of revenue $ 47,815 $ 27,888 Gross profit $ 69,791 $ 46,920

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	The accompanying condensed consolidated financial statements include the accounts of The Original BARK Company and its wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s audited consolidated financial statements as of and for the years ended March 31, 2021 and 2020.
Principles of Consolidation	The consolidated balance sheet as of March 31, 2021, included herein, was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by U.S. GAAP, required on an annual reporting basis. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods. The results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, the year ending March 31, 2022, or any other period.
Use of Estimates	The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions.The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. Except with respect to estimates related to the warrant liabilities, there have been no material changes to the Company’s use of estimates as described in the audited consolidated financial statements as of March 31, 2021.
Fair Value of Financial Instruments	The Company’s financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses, are carried at historical cost. At June 30, 2021 and March 31, 2021, the carrying amounts of these instruments approximated their fair values because of their short-term nature. The carrying amounts of the Company’s long-term debt approximate the fair value based on consideration of current borrowing rates available to the Company. Assets and liabilities recorded at fair value on a recurring basis in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: Level 1 —Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2 —Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and Level 3 —Unobservable inputs that are supported by little or no market data for the related assets or liabilities.
Restricted Cash	The Company has restricted cash with its primary banks related to customs bonds required for the importing of goods.
Concentration of Credit Risk and Major Customers and Suppliers	Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with various domestic financial institutions of high credit quality. The Company’s accounts receivable are derived from sales contracts with large retail customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary.
Recently Issued Accounting Pronouncements Not Yet Adopted	In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the consolidated financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The standard is effective for fiscal years beginning after December 15, 2021, with early adoption permitted. The Company plans to adopt this standard on April 1, 2022 and is continuing to evaluate the expected impact that the standard will have on its consolidated financial statements and related disclosures In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments , which requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. This guidance in the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the impact that the adoption will have on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which is intended to simplify the accounting for income taxes. This updated removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The new standard will be effective beginning April 1, 2022. The Company does not expect the adoption of ASU 2019-12 to have a material impact on the Company’s consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following summarizes assets and liabilities that are measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands): As of June 30, 2021 Level 1 Level 2 Level 3 Total Liabilities Public warrant liability (1) $ 29,505 $ — $ — $ 29,505 Private warrant liability (1) $ — $ 15,862 $ — $ 15,862 Common stock warrant liability (1) $ — $ — $ 797 $ 797 $ 29,505 $ 15,862 $ 797 $ 46,164 As of March 31, 2021 Level 1 Level 2 Level 3 Total Liabilities Preferred stock warrant liabilities (1) $ — $ — $ 133 $ 133 Derivative liabilities (2) — — $ 4,883 $ 4,883 $ — $ — $ 5,016 $ 5,016 ______________ (1) Included in accrued and other current liabilities. (2) Included in other long-term liabilities.

REVENUE FROM CONTRACTS WITH C_2

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	3 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregated Revenue	Disaggregated Revenue Revenue disaggregated by significant revenue stream for the three-months ended June 30, 2021 and 2020 were as follows (in thousands): Three Months Ended June 30, 2021 2020 Revenue Direct to Consumer: Toys and treats subscription $ 103,089 $ 65,608 Other $ 2,287 $ 1,491 Total Direct to Consumer $ 105,376 $ 67,099 Commerce $ 12,230 $ 7,709 Revenue $ 117,606 $ 74,808

DEBT (Tables)

DEBT (Tables)	3 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt	As of June 30, 2021 and March 31, 2021, long-term debt consisted of the following (in thousands): As of June 30, As of March 31, 2021 2021 2025 Convertible Notes $ 75,000 $ 75,000 Western Alliance revolving line of credit & term loan $ — $ 34,300 Convertible promissory notes $ — $ 7,167 PPP loan $ — $ 5,157 $ 75,000 $ 121,624 Less: deferred financing fees and debt discount $ (3,417) $ (5,895) Total long-term debt $ 71,583 $ 115,729

REDEEMABLE CONVERTIBLE PREFER_2

REDEEMABLE CONVERTIBLE PREFERRED STOCK (Tables)	3 Months Ended
	Jun. 30, 2021
Temporary Equity [Abstract]
Schedule of Redeemable Convertible Preferred Stock	The following table summarizes issued and outstanding redeemable convertible preferred stock of Legacy BARK as of both immediately prior to the Merger and March 31, 2021 (in thousands, except share and per share information): Redeemable Convertible Preferred Stock Shares Carrying Value Series Seed 2,057,188 $ 1,897 Series A 2,110,400 4,948 Series B 990,068 10,285 Series C 2,142,188 34,585 Series C-1 452,671 8,272

STOCK-BASED COMPENSTION PLANS (

STOCK-BASED COMPENSTION PLANS (Tables)	3 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of Stock-based Compensation Expense by Function	The following table summarizes the total stock-based compensation expense by function for the three months ended June 30, 2021 and 2020, which includes expense related to options, restricted stock units, and secondary sales (in thousands): Three months ended June 30, 2021 2020 General and administrative $ 3,070 $ 360 Advertising and marketing $ 28 $ 28 Total stock-based compensation expense $ 3,098 $ 388

OTHER INCOME - NET (Tables)

OTHER INCOME - NET (Tables)	3 Months Ended
	Jun. 30, 2021
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense)	Other income—net consisted of the following: Three Months Ended 2021 2020 Other income — net: Other income $ 112 $ 187 Change in fair value of warrants (3,899) — Change in fair value of derivative liability — 34 Loss on extinguishment of debt (2,598) — $ (6,385) $ 221

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	3 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	Basic and diluted loss per share attributable to common stockholders were calculated as follows: Three Months Ended 2021 2020 Numerator: Net income (loss) $ (24,804) $ 2,016 Less: Earnings attributable to participating securities $ — $ (1,583) Net loss attributable to common stockholders—basic and diluted $ (24,804) $ 433 Denominator: Weighted-average number of common shares outstanding—basic and diluted 108,762,540 5,206,474 Weighted average effect of potentially dilutive securities: Effect of potentially dilutive preferred stock $ — 3,333,119 Effect of potentially dilutive stock options to purchase common stock $ — 971,920 Effect of potentially dilutive warrants to purchase common stock $ — 74,342 Effect of potentially dilutive warrants to purchase preferred stock $ — 523 Weighted average common shares outstanding—diluted 108,762,540 9,586,378 Net income (loss) per share attributable to common stockholders Net income (loss) per share attributable to common stockholders - basic $ (0.23) $ 0.08 Net income (loss) per share attributable to common stockholders - diluted $ (0.23) $ 0.05
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share	The Company excluded the following potential common stock, presented based on amounts outstanding at June 30, 2021 from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect. As of June 30, 2021 2020 Stock options to purchase common stock 29,225,320 — Warrants to purchase common stock 13,347,417 — 2025 convertible notes as converted to common stock 7,744,063 —

SEGMENTS (Tables)

SEGMENTS (Tables)	3 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Key financial performance measures of the segments including revenue, cost of revenue, and gross profit are as follows (in thousands): Three Months Ended 2021 2020 Direct to Consumer: Revenue $ 105,376 $ 67,099 Cost of revenue $ 40,819 $ 24,116 Gross profit $ 64,557 $ 42,983 Commerce: Revenue $ 12,230 $ 7,709 Cost of revenue $ 6,996 $ 3,772 Gross profit $ 5,234 $ 3,937 Consolidated: Revenue $ 117,606 $ 74,808 Cost of revenue $ 47,815 $ 27,888 Gross profit $ 69,791 $ 46,920

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS - Narrative (Details)	Jun. 30, 2021keyCategory
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of key categories	4

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		$ 4,883
Total	$ 46,164	5,016
Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	29,505
Private Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	15,862
Common Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	797
Preferred Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		133
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		0
Total	29,505	0
Level 1 | Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	29,505
Level 1 | Private Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 1 | Common Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 1 | Preferred Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		0
Total	15,862	0
Level 2 | Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 2 | Private Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	15,862
Level 2 | Common Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 2 | Preferred Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		4,883
Total	797	5,016
Level 3 | Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 3 | Private Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0
Level 3 | Common Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	$ 797
Level 3 | Preferred Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		$ 133

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Nov. 20, 2020
Concentration Risk [Line Items]
Restricted cash	$ 2,278	$ 1,500	$ 0
Warrants issued per share, percent				0.3333
Accounts Receivable | Customer Concentration Risk | Three Customers
Concentration Risk [Line Items]
Concentration risk, percentage	75.00%	84.00%
Finished Goods | Supplier Concentration Risk | Two Suppliers
Concentration Risk [Line Items]
Concentration risk, percentage	35.00%		40.00%
Accounts Payable | Supplier Concentration Risk | Two Suppliers
Concentration Risk [Line Items]
Concentration risk, percentage	30.00%		44.00%

MERGER - Narrative (Details)

MERGER - Narrative (Details) - USD ($)	Jun. 01, 2021	Jun. 30, 2021	Mar. 31, 2021	Nov. 27, 2020
Business Combination, Separately Recognized Transactions [Line Items]
Recapitalization exchange ratio (in shares)	8.7425
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001	$ 0.0001
Reverse recapitalization, options converted (in shares)	29,257,576
Reverse recapitalization, warrants converted (in shares)	1,897,212
PIPE issuance (in shares)	20,000,000
Sale of stock (USD per share)	$ 10
PIPE issuance consideration	$ 200,000,000
Exercise price of warrants (USD per share)	$ 11.50
Common stock, shares authorized (in shares)	500,000,000	500,000,000	17,000,000
Common Class B
Business Combination, Separately Recognized Transactions [Line Items]
Net equity infusion from the Merger (in shares)	6,358,750
2025 Convertible Notes | Convertible Debt
Business Combination, Separately Recognized Transactions [Line Items]
Debt interest rate	5.50%			5.50%
Debt instrument, convertible, number of equity instruments (in shares)	7,713,121

REVENUE FROM CONTRACTS WITH C_3

REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule of Disaggregated Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 117,606	$ 74,808
Direct to Consumer:
Disaggregation of Revenue [Line Items]
Revenue	105,376	67,099
Commerce
Disaggregation of Revenue [Line Items]
Revenue	12,230	7,709
Toys and treats subscription | Direct to Consumer:
Disaggregation of Revenue [Line Items]
Revenue	103,089	65,608
Other | Direct to Consumer:
Disaggregation of Revenue [Line Items]
Revenue	$ 2,287	$ 1,491

REVENUE FROM CONTRACTS WITH C_4

REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Contractual liabilities included in deferred revenue	$ 30,654	$ 27,177
Contractual liabilities included in deferred revenue, revenue recognized	$ 4,800

DEBT - Schedule of Debt (Detail

DEBT - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Long-term debt, gross	$ 75,000	$ 121,624
Less: deferred financing fees and debt discount	(3,417)	(5,895)
Total long-term debt	71,583	115,729
Convertible Debt | 2025 Convertible Notes
Debt Instrument [Line Items]
Long-term debt, gross	75,000	75,000
Convertible Debt | Convertible promissory notes
Debt Instrument [Line Items]
Long-term debt, gross	0	7,167
Total long-term debt			$ 7,200
Line of Credit and Term Loan | Western Alliance revolving line of credit & term loan
Debt Instrument [Line Items]
Long-term debt, gross	0	34,300
Loans Payable | PPP loan
Debt Instrument [Line Items]
Long-term debt, gross	$ 0	$ 5,157

DEBT - Western Alliance Bank -

DEBT - Western Alliance Bank - Line of Credit and Term Loan Narrative (Details) - USD ($)	Jan. 22, 2021	Nov. 27, 2020	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021	Dec. 07, 2018	Oct. 31, 2017
Debt Instrument [Line Items]
Payments of long-term debt			$ 39,457,000	$ 0
Total long-term debt			71,583,000		$ 115,729,000
Line of Credit | Western Alliance Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity							$ 35,000,000
Debt instrument, interest rate floor	0.50%
Borrowing base, percentage	80.00%
Total long-term debt			0		$ 34,300,000
Line of credit facility, remaining borrowing capacity			$ 35,000,000
Line of Credit | Western Alliance Agreement | Revolving Credit Facility | Prime Rate
Debt Instrument [Line Items]
Basis spread on variable rate	5.25%
Term Loan | Western Alliance Agreement
Debt Instrument [Line Items]
Debt instrument, face amount						$ 10,000,000
Payments of long-term debt		$ 10,000,000
Extinguishment of debt, early repayment fee		$ 200,000
Incremental Seasonal Loan | Western Alliance Agreement
Debt Instrument [Line Items]
Debt instrument, face amount						$ 5,000,000

DEBT - Convertible Promissory N

DEBT - Convertible Promissory Notes Narrative (Details)	Jun. 01, 2021USD ($)shares	May 01, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)debtClosing	Jun. 30, 2021USD ($)shares	Jun. 30, 2020USD ($)	Mar. 31, 2021USD ($)	Jun. 18, 2020USD ($)	Dec. 19, 2019USD ($)
Debt Instrument [Line Items]
Proceeds from convertible notes					$ 0	$ 1,000,000
Total long-term debt					71,583,000		$ 115,729,000
Loss on extinguishment of debt					$ 2,598,000	$ 0
Common Stock
Debt Instrument [Line Items]
Debt instrument, convertible, value of equity instruments	$ 12,700,000
Conversion of preferred shares (in shares) | shares	1,135,713				1,135,713
Convertible Debt | Convertible promissory notes
Debt Instrument [Line Items]
Total long-term debt			$ 7,200,000
Loss on extinguishment of debt	$ 2,600,000
Equity component of convertible debt	$ 700,000
Convertible Debt | Convertible Promissory Notes - 2019
Debt Instrument [Line Items]
Debt instrument, face amount (up to)									$ 10,000,000
Proceeds from convertible notes				$ 3,900,000
Number of debt closings | debtClosing				2
Debt interest rate				7.00%
Convertible Debt | Convertible Promissory Notes - 2020
Debt Instrument [Line Items]
Debt instrument, face amount (up to)			10,000,000					$ 800,000
Proceeds from convertible notes		$ 1,000,000	$ 1,500,000
Convertible Debt | Convertible Promissory Notes - 2020, Super Pro Rata Notes
Debt Instrument [Line Items]
Debt interest rate				10.00%
Convertible Debt | Convertible Promissory Notes - 2020, Pro Rata Notes
Debt Instrument [Line Items]
Debt interest rate				8.00%

DEBT - Paycheck Protection Plan

DEBT - Paycheck Protection Plan Program (Details) - USD ($) $ in Thousands	Apr. 24, 2020	Jun. 30, 2021	Jun. 30, 2020
Debt Instrument [Line Items]
Proceeds from debt		$ 0	$ 5,157
PPP loan | Loans Payable
Debt Instrument [Line Items]
Proceeds from debt	$ 5,200

DEBT - 2025 Convertible Notes N

DEBT - 2025 Convertible Notes Narrative (Details) - USD ($)	Nov. 27, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 01, 2021	Mar. 31, 2021
Debt Instrument [Line Items]
Proceeds from convertible notes		$ 0	$ 1,000,000
Payments of debt issuance costs		494,000	42,000
Payments of long-term debt		39,457,000	$ 0
2025 Convertible Notes | Convertible Debt
Debt Instrument [Line Items]
Debt instrument, face amount	$ 75,000,000
Proceeds from convertible notes	74,700,000
Payments of debt issuance costs	300,000
Debt instrument, additional principal amount available for issuance	$ 25,000,000
Debt interest rate	5.50%			5.50%
Debt instrument, debt default, interest rate increase	3.00%
Convertible debt		$ 75,000,000			$ 75,000,000
Amended Western Alliance Agreement and Pinnacle Agreement | Term Loan
Debt Instrument [Line Items]
Payments of long-term debt	$ 27,600,000

REDEEMABLE CONVERTIBLE PREFER_3

REDEEMABLE CONVERTIBLE PREFERRED STOCK - Issued and Outstanding Redeemable Convertible Preferred Stock (Details) - USD ($) $ in Thousands	Jun. 30, 2021	May 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)	0		7,752,515	7,752,515	7,752,515
Redeemable convertible preferred stock	$ 0		$ 59,987	$ 59,987	$ 59,987
Convertible preferred stock, shares issued (in shares)	0		7,752,515
Series Seed
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)		2,057,188	2,057,188
Redeemable convertible preferred stock		$ 1,897	$ 1,897
Convertible preferred stock, shares issued (in shares)		2,057,188	2,057,188
Series A
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)		2,110,400	2,110,400
Redeemable convertible preferred stock		$ 4,948	$ 4,948
Convertible preferred stock, shares issued (in shares)		2,110,400	2,110,400
Series B
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)		990,068	990,068
Redeemable convertible preferred stock		$ 10,285	$ 10,285
Convertible preferred stock, shares issued (in shares)		990,068	990,068
Series C
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)		2,142,188	2,142,188
Redeemable convertible preferred stock		$ 34,585	$ 34,585
Convertible preferred stock, shares issued (in shares)		2,142,188	2,142,188
Series C-1
Preferred Units [Line Items]
Convertible preferred stock, shares outstanding (in shares)		452,671	452,671
Redeemable convertible preferred stock		$ 8,272	$ 8,272
Convertible preferred stock, shares issued (in shares)		452,671	452,671

REDEEMABLE CONVERTIBLE PREFER_4

REDEEMABLE CONVERTIBLE PREFERRED STOCK - Narrative (Details) - shares	Jun. 01, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020
Preferred Units [Line Items]
Recapitalization exchange ratio (in shares)	8.7425
Convertible preferred stock, shares authorized (in shares)		0	8,010,560
Convertible preferred stock, shares outstanding (in shares)		0	7,752,515	7,752,515	7,752,515
Convertible Redeemable Preferred Stock
Preferred Units [Line Items]
Convertible preferred stock, shares authorized (in shares)		0
Convertible preferred stock, shares outstanding (in shares)		0

STOCK-BASED COMPENSTION PLANS -

STOCK-BASED COMPENSTION PLANS - Stock Option Plans Narrative (Details) - shares	Jun. 01, 2021	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reverse recapitalization, options converted (in shares)	29,257,576
Minimum exercise price, percentage of common share grant date fair value	100.00%
First Anniversary
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	25.00%
One Thirty-Sixth on a Monthly Basis
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	75.00%
Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	10 years
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	16,929,505
Number of shares available for grant (in shares)		16,929,505
Maximum annual increase in shares , percentage of shares issued and outstanding	5.00%
2011 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reverse recapitalization, options converted (in shares)	29,390,344
Number of shares available for grant (in shares)		0

STOCK-BASED COMPENSTION PLANS_2

STOCK-BASED COMPENSTION PLANS - Stock Option Activity Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	397,780
Weighted average exercise price (USD per share)	$ 9.62
Stock-based compensation expense	$ 3,098	$ 388
Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years

STOCK-BASED COMPENSTION PLANS_3

STOCK-BASED COMPENSTION PLANS - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 3,098	$ 388
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,070	360
Advertising and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 28	$ 28

STOCK-BASED COMPENSTION PLANS_4

STOCK-BASED COMPENSTION PLANS - Employee Stock Purchase Plan Narrative (Details) - Employee Stock	1 Months Ended
	Jun. 30, 2021shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	3,385,901
Maximum annual increase in shares , percentage of shares issued and outstanding	1.00%
Number of shares authorized, maximum annual increase, number of shares (in shares)	1,500,000

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($)	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Federal, state, or foreign income tax provision (benefit)	$ 0	$ 0

OTHER INCOME - NET - Schedule o

OTHER INCOME - NET - Schedule of Other Income - Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Other income—net:
Other income	$ 112	$ 187
Change in fair value of warrants	(3,899)	0
Change in fair value of derivative liability	0	34
Loss on extinguishment of debt	(2,598)	0
Other income - net	$ (6,385)	$ 221

NET LOSS PER SHARE - Calculatio

NET LOSS PER SHARE - Calculation of Basic and Diluted Loss per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Numerator [Abstract]
Net income (loss)	$ (24,804)	$ 2,016
Less: Earnings attributable to participating securities	0	(1,583)
Less: Earnings attributable to participating securities	0	(1,583)
Net loss attributable to common stockholders - basic	(24,804)	433
Net loss attributable to common stockholders - diluted	$ (24,804)	$ 433
Denominator [Abstract]
Weighted-average number of common shares outstanding—basic (in shares)	108,762,540	5,206,474
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive preferred stock (in shares)	0	3,333,119
Effect of potentially dilutive stock options to purchase common stock (in shares)	0	971,920
Effect of potentially dilutive warrants to purchase common stock (in shares)	0	74,342
Effect of potentially dilutive warrants to purchase preferred stock (in shares)	0	523
Weighted-average number of common shares outstanding—diluted (in shares)	108,762,540	9,586,378
Net income (loss) per share attributable to common stockholders
Net income (loss) per common share attributable to common stockholders - basic (USD per share)	$ (0.23)	$ 0.08
Net income (loss) per common share attributable to common stockholders - diluted (USD per share)	$ (0.23)	$ 0.05

NET LOSS PER SHARE - Schedule o

NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	29,225,320	0
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	13,347,417	0
2025 convertible notes as converted to common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	7,744,063	0

SEGMENTS - Narrative (Details)

SEGMENTS - Narrative (Details)	3 Months Ended
	Jun. 30, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	2

SEGMENTS - Schedule of Gross Pr

SEGMENTS - Schedule of Gross Profit by Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Revenue	$ 117,606	$ 74,808
Cost of revenue	47,815	27,888
Gross profit	69,791	46,920
Direct to Consumer:
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Revenue	105,376	67,099
Cost of revenue	40,819	24,116
Gross profit	64,557	42,983
Commerce
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Revenue	12,230	7,709
Cost of revenue	6,996	3,772
Gross profit	$ 5,234	$ 3,937